Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: Insights from GUSTO I Economics and Quality of Life substudy☆
To access this article, please choose from the options below
☆ Supported by grants from Bayer (New York, NY), Genentech, Inc. (South San Francisco, Calif), CIBA-Corning (Medfor, Mass), ICI Pharmaceuticals (Wilmington, Del), and Sanofi Pharmaceuticals (Paris, France).
PII: S0002-8703(04)00259-5
doi:10.1016/j.ahj.2004.04.046
© 2004 Elsevier Inc. All rights reserved.
